Germline Gene Therapy: Promise and Peril
Needs Statement
Physicians, fellows, residents, medical students, and other healthcare professionals need to receive regular updates on practice guidelines, the latest scientific advances, and translational efforts in the field of Obstetrics and Gynecology. The series aims to increase the knowledge and skills of the learners in select topic areas to improve the diagnosis, treatment, and management of obstetric and gynecologic disorders. The series will also address unique ethical challenges in the field.
Target Audience
Physicians, medical students, fellows, residents, and other health professionals.
Learning Objectives
- Describe mitochondrial replacement therapy (MRT) and its clinical indications.
- Review heritable human genome editing (HHGE) for the prevention of genetic disease transmission.
- Assess in-vitro gametogenesis (IVG) by somatic cell haploidization.
- Summarize the safety and ethical issues associated with germline gene therapy.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Price
Thank you for reviewing this Baylor College of Medicine on-demand activity. In order to complete the evaluation and claim credit for your participation, please select the appropriate payment option above. After payment has been completed, you will receive an email confirmation and receipt.
For any questions, contact cpd@bcm.edu.